Navigation Links
ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
Date:7/6/2010

CHICAGO, July 6 /PRNewswire/ -- ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), has been engaged to sell a patent portfolio of near-infrared spectroscopy technology owned by NIResults Inc. The portfolio includes over 90 issued US and foreign patents and patent applications.  The assets have been cited by over 20 companies including Abbott Laboratories, Baxter International, Bayer Healthcare, Beckman Coulter Inc., Xerox, and Hewlett Packard.

(Logo: http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100614/CG20517LOGO)

The patents of this portfolio cover the use of near-infrared spectroscopy in clinical chemistry analysis systems, pulse oximeters and CO-oximeters, non-invasive glucose monitors, and hemoglobin monitors. The patents describe a method for the monitoring of key blood analytes without the need for costly, environmentally challenging, chemical reagents. The assets also include in-vitro, which is applied to a droplet of blood from a sample, and in-vivo (non-invasive) technology, which does not require a blood sample. Using near-infrared spectroscopy technology to count analytes in the blood eliminates the disadvantages associated with conventional methods such as the risk of patient infection and discomfort from invasive sampling methods and erroneous test results due to time delays between when the blood is drawn and analyzed.

"This portfolio will provide the purchaser with the coverage necessary to develop next generation monitoring devices," said Dean Becker, ICAP Ocean Tomo CEO. This portfolio should be of interest to any entity involved in diabetes management or blood monitoring markets, or developing products for analyte measurement.

To learn more about the patents available for sale in this portfolio or how to sell or buy intellectual property please contact ICAP Ocean Tomo at 1-866-779-8363 or at patent.brokerage@us.icap.com.

About ICAP Ocean Tomo LLC

ICAP Ocean Tomo is the intellectual property brokerage division of ICAP.

About ICAP

ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP is also the source of global market information and research for professionals in the international financial markets. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to www.icap.com.


'/>"/>
SOURCE ICAP Ocean Tomo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
2. Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
3. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
4. HealthWarehouse.com Now Offers Over 1,000 Medications Under $25 Bringing Increased Affordability to Consumers
5. BSGI Offers Improved Cancer Detection for Negative or Indeterminate Mammograms
6. In the Face of Pain® Offers Social Media 101 for Pain Management Advocates
7. Medicalequipmentpro.com Offers Fathers Day Discounts to Ensure this Fathers Day is a Healthy One
8. Prolifiq Offers Best Practices Solution for Selling Medical Devices in Tough Regulatory Environment
9. Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)
10. Blog Contest Offers Graduate Students the Chance to Win a Trip to Zambia
11. BSGI Offers Clear View of Breast Tumor Response to Neoadjuvant Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)...  Physical Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation ... . The reputable clinic will continue to be co-owned ... his staff of four clinicians. Lipkin received his doctorate in ... 10 years of experience with a strong background in manual ... the 10th PRN clinic in and around the Denver ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
(Date:8/3/2017)... 3, 2017  Opioid addiction and other drugs of ... costs and threatening outcomes, were problems taken on directly ... industry that support them, met this week. This according ... that drugs of abuse, procalcitonin and acute kidney injury ... organization,s 69th meeting in San Diego, CA. ...
Breaking Medicine Technology:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... care professionals, today announced that it has raised $1.675 M in seed funding ... Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s primary ...
(Date:8/17/2017)... Ca (PRWEB) , ... August 17, 2017 , ... Centrifugation ... useful tools in the laboratory that we can no longer do without. And just ... the lifetime of your device. , In this webinar, attendees will learn about the ...
(Date:8/16/2017)... , ... August 16, 2017 , ... The next Patient ... being accepted. , Students who successfully complete the seven-week long Patient Care Academy ... Assistant (CNA). The average starting salary for a CNA in Kalamazoo is $24,428.* , ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Data Council, ... that it was acquired by Advantage Solutions. The Data Council’s IX-ONE platform ... include the industry’s leading suppliers, brokers, distributors and retailers. The Data Council will ...
(Date:8/16/2017)... ... August 16, 2017 , ... QualDerm Partners , a ... today announced Cumberland Skin Surgery and Dermatology has joined the company ... in both Hermitage and Lebanon, Tennessee, provides comprehensive general dermatology and skin cancer ...
Breaking Medicine News(10 mins):